Hospital pharmacists can play an instrumental role in controlling the misuse of opioids while ensuring appropriate pain management for their patients.
This case highlights the importance of recognizing ICPI-AKI, implementing effective therapeutic interventions, and understanding the clinical context to prevent irreversible renal damage.
The NJSHP's 2nd Annual Symposium fosters networking and education for pharmacy professionals, featuring expert insights on compliance and regulation in pharmacy compounding.
Infectious Disease Society of America and Society for Healthcare Epidemiology of America make 3 new treatment recommendations for adults.
Cynthia Ryan, PharmD, BCPS, discusses practical, evidence-based strategies for pharmacists to identify, prevent, and manage dermatologic toxicities associated with cancer therapies, emphasizing interdisciplinary collaboration, patient education, and proactive supportive care to improve adherence and outcomes.
Pharmacists can address the needs of health care consumers earlier in the care journey by building interpersonal relationships and community trust, as well as by leading institutional and public policy reform.
Bispecific therapies require clearer terminology to improve safety and communication.
Pharmacists are positioned to significantly impact weight management by offering accessible expertise in medication, lifestyle guidance, and long-term support for healthier choices.
The panel of pneumococcal vaccination experts offer their concluding insights and perspectives on the current landscape of pneumococcal vaccines.
When a patient is engaged in the home by a team that includes a pharmacist resource, social determinants of health issues become more clear and the care team can help close the gaps.
Major pharmacogenomics organizations continue to recognize the potential relevance of pharmacogenomics for psychiatric medication management, mainly due to its effects on pharmacokinetics.
Government’s database include health care professionals in many categories, including pharmacists.
Accurate medication reconciliations are critical for ensuring safe patient outcomes, and a correct medication list can help prevent drug-drug interactions, contraindications, and duplicate therapies.
Periodontitis and AD are both characterized by inflammatory and immunological response by the host.
Let’s shine the spotlight on ourselves, and let’s begin to heal.
Pharmacists can step up counseling and advocate for best practices for children with chronic illnesses.
Pharmacist-led post-cardiovascular surgery outpatient glycemic management services help reduce hospital readmissions and sternal wound infections in patients with uncontrolled diabetes who recently underwent an interventional cardiology procedure.
It is important for pharmacists to educate patients, especially those with cardiovascular risks, about the differences between fish oil supplements and prescription n3-FAs products.
Panelists discuss how advancing chronic graft-vs-host disease (cGVHD) management involves improving steroid response rates, exploring combination therapies, utilizing biomarkers for personalized treatment, and striving for steroid-free first-line options to enhance patient outcomes and reduce long-term adverse effects.
Specialty pharmacists—those caring for patients with serious, sometimes life-threatening conditions such as cancer or rheumatologic disease—are not immune from the ongoing labor crisis.
A pharmacist-led transitions of care program reduced chronic obstructive pulmonary disease readmissions by implementing guideline-based inhaler prescribing and addressing medication adherence barriers, decreasing 30-day readmission rates.
New technology and innovation may help turn the corner on antibiotic resistance.
Philip Kuball, MD, neurology resident at NYU Langone Health, highlights the integral role of pharmacists in monitoring patient eligibility, managing dosing schedules, and ensuring safe medication interactions for lecanemab treatment in Alzheimer disease.
Technology is key in supporting and freeing up time for pharmacists to meet vaccination efforts and increased demands in providing community care.
Non–FDA-approved medications may be accessed for patient care via 3 alternative pathways: expanded access, the Right to Try Act, and off-label use, which are reviewed in this article.
Small and/or rural hospitals present a great opportunity for self-development and actualization.
Pharmacists can be instrumental in reducing the main challenges in opioid use disorder—namely supply, demand, and harm.